- CAR T therapy for multiple sclerosis enters US trials for first time. Hopes are high that engineered immune cells, which are already in use to treat blood cancer, will halt the progression of a degenerative autoimmune disorder. https://www.nature.com/articles/d41586-024-00470-5 3 comments futurology